- Lobbying
- Lobbying by Tiber Creek Group (obo Jazz Pharmaceuticals)
Lobbying Relationship
Bills mentioned
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Bryant Hall | Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham Staff Director, Sen. Veterans Affairs Committee (2003-2004); Legislative Director, Sen. Bob Graham (1999-2003) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to the Food and Drug Administration and appropriations..
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Budget
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Registration
Issue(s) they said they’d lobby about: Issues related to the Food and Drug Administration and appropriations..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate